The role of extracellular adenosine in chemical neurotransmission in the hippocampus and basal ganglia: Pharmacological and clinical aspects

Current Topics in Medicinal Chemistry

Volumn 11, Issue 8, 2011, Pages 1034-1046

  Sperlágh, Beáta ^a   Vizi, E Sylvester ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

A1 receptor; A2A receptor; Adenosine; ATP; Hippocampus; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CAFFEINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; ISTRADEFYLLINE; LEVODOPA; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASAL GANGLION; BRAIN INJURY; BRAIN ISCHEMIA; DYSKINESIA; ELECTROPHYSIOLOGY; EPILEPSY; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; ISCHEMIA; LESCH NYHAN SYNDROME; MENTAL DISEASE; MULTIPLE SCLEROSIS; NERVE CELL NETWORK; NERVE EXCITABILITY; NEUROCHEMISTRY; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; TREMOR;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BASAL GANGLIA; EXTRACELLULAR SPACE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; ISCHEMIA; MICE; NERVE NET; NEUROGLIA; NEURONS; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; PURINERGIC P1 RECEPTOR AGONISTS; PURINERGIC P1 RECEPTOR ANTAGONISTS; RATS; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION;

EID: 79954507325     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802611795347564     Document Type: Article

References (176)

1. Drury, A. N.; Szent-Gyorgyi, A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol., 1929, 68, 213-237.
2. Sattin, A.; Rall, T. W. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol., 1970, 6, 13-23.
3. Pull, I.; McIlwain, H. Adenine derivatives as neurohumoral agents in the brain. The quantities liberated on excitation of superfused cerebral tissues. Biochem. J., 1972, 130, 975-981.
4. Gustafsson, L.; Hedqvist, P.; Fredholm, B. B.; Lundgren, G. Inhibition of acetylcholine release in guinea pig ileum by adenosine. Acta Physiol. Scand, 1978, 104, 469-478.
5. Vizi, E. S.; Knoll, J. The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine. Neuroscience, 1976, 1, 391-398.
6. Burnstock, G. A Basis for Distinguishing Two Types of Purinergic Receptor. in: cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. Straub, R. Bolis, L. Ed. Raven Press: New York, 1978; pp 107-008.
7. Gu, J. G.; MacDermott, A. B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature, 1997, 389, 749-753.
8. Sanchez-Nogueiro, J.; Marin-Garcia, P.; Leon, D.; Leon-Otegui, M.; Salas, E.; Gomez-Villafuertes, R.; Gualix, J.; Miras-Portugal, M. T. Axodendritic fibres. of mouse cerebellar granule neurons exhibit a diversity of functional P2X receptors. Neurochem. Int., 2009, 55, 671-682.
9. Sperlagh, B.; Vizi, E. S. Effect of presynaptic P2 receptor stimulation on transmitter release. J. Neurochem., 1991, 56, 1466-1470.
10. Wall, M. J.; Atterbury, A.; Dale, N. Control of basal extracellular adenosine concentration in rat cerebellum. J. Physiol., 2007, 582, 137-151.
11. Vizi, E. S.; Fekete, A.; Karoly, R.; Mike, A. Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br. J. Pharmacol., 2010, 160,785-809.
12. Bours, M. J.; Swennen, E. L.; Di Virgilio, F.; Cronstein, B. N.; Dagnelie, P. C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther., 2006, 112, 358-404.
13. Hasko, G.; Pacher, P.; Vizi, E. S.; Illes, P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci., 2005, 26, 511-516.
14. Di Virgilio, F. Purinergic mechanism in the immune system: A signal of danger for dendritic cells. Purinergic Signal., 2005, 1, 205-209.
15. Burnstock, G. Purine and pyrimidine receptors. Cell Mol. Life Sci., 2007, 64, 1471-1483.
16. Fredholm, B. B.; AP, I. J.; Jacobson, K. A.; Klotz, K. N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 2001, 53, 527-552.
17. Dunwiddie, T. V.; Diao, L.; Proctor, W. R. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci., 1997, 17, 7673-7682.
18. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res., 1999, 823, 183-190.
19. Sperlágh, B. Neuronal synthesis, storage and release of ATP. Semin. Neurosci., 1996, 8, 175-186.
20. Coco, S.; Calegari, F.; Pravettoni, E.; Pozzi, D.; Taverna, E.; Rosa, P.; Matteoli, M.; Verderio, C. Storage and release of ATP from astrocytes in culture. J. Biol. Chem., 2003, 278, 1354-1362.
21. Hamilton, N. B.; Attwell, D. Do astrocytes really exocytose neurotransmitters? Nat. Rev. Neurosci., 2010, 11, 227-238.
22. Latini, S.; Pedata, F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem., 2001, 79, 463-484.
23. Sperlagh, B.; Vizi, E. S. Regulation of purine release. In: Handbook of Experimental Pharmacology, Abbracchio, M. P.; Williams, M. Eds. Springer: 2000; Vol. 151, pp: 179-209.
24. Jonzon, B.; Fredholm, B. B. Release of purines, noradrenaline, and GABA from rat hippocampal slices by field stimulation. J. Neurochem., 1985, 44, 217-224.
25. Cunha, R. A.; Vizi, E. S.; Ribeiro, J. A.; Sebastiao, A. M. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high-but not low-frequency stimulation of rat hippocampal slices. J. Neurochem., 1996, 67, 2180-2187.
26. Pedata, F.; Latini, S.; Pugliese, A. M.; Pepeu, G. Investigations in to the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neurochem., 1993, 61, 284-289.
27. Pedata, F.; Pazzagli, M.; Tilli, S.; Pepeu, G. Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch. Pharmacol., 1990, 342, 447-453.
28. Wieraszko, A.; Goldsmith, G.; Seyfried, T. N. Stimulationdependent release of adenosine triphosphate from hippocampal slices. Brain Res., 1989, 485, 244-250.
29. Pedata, F.; Pazzagli, M.; Pepeu, G. Endogenous adenosine release from hippocampal slices: excitatory amino acid agonists stimulate release, antagonists reduce the electrically-evoked release. Naunyn Schmiedebergs Arch. Pharmacol., 1991, 344, 538-543.
30. Sperlagh, B.; Baranyi, M.; Hasko, G.; Vizi, E. S. Potent effect of Interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J. Neuroimmunol., 2004, 151, 33-39.
31. Vizi, E. S.; Sperlagh, B.; Baranyi, M. Evidence that ATP released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neuroscience, 1992, 50, 455-465.
32. Ballarin, M.; Fredholm, B. B.; Ambrosio, S.; Mahy, N. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand, 1991, 142, 97-103.
33. Pazzagli, M.; Pedata, F.; Pepeu, G. Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur. J. Pharmacol., 1993, 234, 61-65.
34. Sciotti, V. M.; Park, T. S.; Berne, R. M.; Van Wylen, D. G. Changes in extracellular adenosine during chemical or electrical brain stimulation. Brain Res., 1993, 613, 16-20.
35. Van Wylen, D. G.; Park, T. S.; Rubio, R.; Berne, R. M. Increases in cerebral Interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab., 1986, 6, 522-528.
36. Dobolyi, A.; Reichart, A.; Szikra, T.; Szilagyi, N.; Kekesi, A. K.; Karancsi, T.; Slegel, P.; Palkovits, M.; Juhasz, G. Analysis of purine and pyrimidine bases, nucleosides and deoxynucleosides in brain microsamples (microdialysates and micropunches) and cerebrospinal fluid. Neurochem. Int., 1998, 32, 247-256.
37. Dobolyi, A.; Szikra, T.; Kekesi, A. K.; Kovacs, Z.; Juhasz, G. Uridine is released by depolarization and inhibits unit activity in the rat hippocampus. Neuroreport, 1999, 10, 3049-3053.
38. 2+ ion fluxes in rat brain homogenates. Neuroreport, 1999, 10, 1577-1582.
39. Verderio, C.; Matteoli, M. ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J. Immunol., 2001, 166, 6383-6391.
40. 7 receptor inhibition improves recovery after spinal cord injury. Nat. Med., 2004, 10, 821-827.
41. Wang, Y.; Roman, R.; Lidofsky, S. D.; Fitz, J. G. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc. Natl. Acad. Sci. USA, 1996, 93, 12020-12025.
42. Hagberg, H.; Andersson, P.; Lacarewicz, J.; Jacobson, I.; Butcher, S.; Sandberg, M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem., 1987, 49, 227-231.
43. Hisanaga, K.; Onodera, H.; Kogure, K. Changes in levels of purine and pyrimidine nucleotides during acute hypoxia and recovery in neonatal rat brain. J. Neurochem., 1986, 47, 1344-1350.
44. Lutz, P. L.; Kabler, S. Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia. Brain Res., 1997, 769, 281-286.
45. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Hanau, S.; Di Virgilio, F. Purinergic modulation of Interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med., 1997, 185, 579-582.
46. 7 receptors. Neurochem. Int., 1998, 33, 209-215.
47. Fowler, J. C. Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice. Naunyn Schmiedebergs Arch. Pharmacol., 1993, 347, 73-78.
48. Fredholm, B. B.; Dunwiddie, T. V.; Bergman, B.; Lindstrom, K. Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res., 1984, 295, 127-136.
49. Frenguelli, B. G.; Llaudet, E.; Dale, N. High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem., 2003, 86, 1506-1515.
50. Frenguelli, B. G.; Wigmore, G.; Llaudet, E.; Dale, N. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem., 2007, 101, 1400-1413.
51. Latini, S.; Corsi, C.; Pedata, F.; Pepeu, G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem. Int., 1995, 27, 239-244.
52. Lloyd, H. G.; Fredholm, B. B. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int., 1995, 26, 387-395.
53. Lloyd, H. G.; Lindstrom, K.; Fredholm, B. B. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int., 1993, 23, 173-185.
54. Andine, P.; Rudolphi, K. A.; Fredholm, B. B.; Hagberg, H. Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmacol., 1990, 100, 814-818.
55. Dux, E.; Fastbom, J.; Ungerstedt, U.; Rudolphi, K.; Fredholm, B. B. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res., 1990, 516, 248-256.
56. 1 receptor agonist and antagonist on neuronal and astrocytic Intermediary metabolism studied with ex vivo 13C NMR spectroscopy. J. Neurochem., 2000, 74, 327-333.
57. Melani, A.; Pantoni, L.; Corsi, C.; Bianchi, L.; Monopoli, A.; Bertorelli, R.; Pepeu, G.; Pedata, F. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke, 1999, 30, 2448-2454; discussion 2455.
58. Zetterstrom, T.; Vernet, L.; Ungerstedt, U.; Tossman, U.; Jonzon, B.; Fredholm, B. B. Purine levels in the Intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci. Lett., 1982, 29, 111-115.
59. Dale, N.; Frenguelli, B. G. Release of adenosine and ATP during ischemia and epilepsy. Curr. Neuropharmacol., 2009, 7, 160-179.
60. Sperlagh, B.; Szabo, G.; Erdelyi, F.; Baranyi, M.; Vizi, E. S. Homo-and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system. Br. J. Pharmacol., 2003, 139, 623-633.
61. Zimmermann, H. Ectonucleotidases in the nervous system. Novartis Found. Symp., 2006, 276, 113-128; discussion 128-130, 233-237, 275-281.
62. Wang, T. F.; Guidotti, G. Widespread expression of ecto-apyrase (CD39) in the central nervous system. Brain Res., 1998, 790, 318-322.
63. Wang, T. F.; Rosenberg, P. A.; Guidotti, G. Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase (CD39) gene. Brain Res. Mol. Brain Res., 1997, 47, 295-302.
64. Sperlagh, B.; Vizi, E. S. Extracellular Interconversion of nucleotides reveals an ecto-adenylate kinase activity in the rat hippocampus. Neurochem. Res., 2007, 32, 1978-1989.
65. Cunha, R. A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int., 2001, 38, 107-125.
66. Grondal, E. J.; Janetzko, A.; Zimmermann, H. Monospecific antiserum against 5'-nucleotidase from Torpedo electric organ: immunocytochemical distribution of the enzyme and its association with Schwann cell membranes. Neuroscience, 1988, 24, 351-363.
67. Schoen, S. W.; Graeber, M. B.; Reddington, M.; Kreutzberg, G. W. Light and electron microscopical immunocytochemistry of 5'-nucleotidase in rat cerebellum. Histochemistry, 1987, 87, 107-113.
68. Cunha, R. A.; Sebastiao, A. M.; Ribeiro, J. A. Ecto-5'-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat. J. Neurochem., 1992, 59, 657-666.
69. James, S.; Richardson, P. J. Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J. Neurochem., 1993, 60, 219-227.
70. rd Ed.; Vizi, E. S. Hamon, M, Eds. Springer: New York, 2008; Vol. 2, PP 227-255.
71. Dare, E.; Schulte, G.; Karovic, O.; Hammarberg, C.; Fredholm, B. B. Modulation of glial cell functions by adenosine receptors. Physiol. Behav., 2007, 92, 15-20.
72. Cass, C. E.; Young, J. D.; Baldwin, S. A.; Cabrita, M. A.; Graham, K. A.; Griffiths, M.; Jennings, L. L.; Mackey, J. R.; Ng, A. M.; Ritzel, M. W.; Vickers, M. F.; Yao, S. Y. Nucleoside transporters of mammalian cells. Pharm. Biotechnol., 1999, 12, 313-352.
73. Thorn, J. A.; Jarvis, S. M. Adenosine transporters. Gen. Pharmacol., 1996, 27, 613-620.
74. Pascual, O.; Casper, K. B.; Kubera, C.; Zhang, J.; Revilla-Sanchez, R.; Sul, J. Y.; Takano, H.; Moss, S. J.; McCarthy, K.; Haydon, P. G. Astrocytic purinergic signaling coordinates synaptic networks. Science, 2005, 310, 113-116.
75. Latini, S.; Bordoni, F.; Pedata, F.; Corradetti, R. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol., 1999, 127, 729-739.
76. Sebastiao, A. M.; Ribeiro, J. A. Tuning and fine-tuning of synapses with adenosine. Curr. Neuropharmacol., 2009, 7, 180-194.
77. Cunha, R. A.; Correia-de-Sa, P.; Sebastiao, A. M.; Ribeiro, J. A. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol., 1996, 119, 253-260.
78. 2A receptormediated facilitation of plasticity. Neurochem. Int., 2008, 52, 65-72.
79. Sebastiao, A. M.; Stone, T. W.; Ribeiro, J. A. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br. J. Pharmacol., 1990, 101, 453-459.
80. 1 receptors. J. Neurosci., 2010, 30, 545-55.
81. Dunwiddie, T. V.; Masino, S. A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 2001, 24, 31-55.
82. Straiker, A. J.; Borden, C. R.; Sullivan, J. M. G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J. Neurosci., 2002, 22, 2460-2468.
83. Serrano, A.; Haddjeri, N.; Lacaille, J. C.; Robitaille, R. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci., 2006, 26, 5370-5382.
84. Zhang, J. M.; Wang, H. K.; Ye, C. Q.; Ge, W.; Chen, Y.; Jiang, Z. L.; Wu, C. P.; Poo, M. M.; Duan, S. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron, 2003, 40, 971-982.
85. 2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum. J. Neurochem., 2009, 110, 1921-1930.
86. Malenka, R. C.; Kocsis, J. D. Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro. J. Neurosci., 1988, 8, 3750-3756.
87. Lovinger, D. M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology, 2010, 58, 951-961.
88. Shen, W.; Flajolet, M.; Greengard, P.; Surmeier, D. J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science, 2008, 321, 848-851.
89. Flajolet, M.; Wang, Z.; Futter, M.; Shen, W.; Nuangchamnong, N.; Bendor, J.; Wallach, I.; Nairn, A. C.; Surmeier, D. J.; Greengard, P. FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci., 2008, 11, 1402-1409.
90. Burnstock, G. Purinergic nerves. Pharmacol. Rev., 1972, 24, 509-581.
91. Fredholm, B. B.; Chen, J. F.; Cunha, R. A.; Svenningsson, P.; Vaugeois, J. M. Adenosine and brain function. Int. Rev. Neuro-Biol., 2005, 63, 191-270.
92. 2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J. Neurochem., 1994, 63, 207-214.
93. 2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release. Naunyn Schmiedebergs Arch. Pharmacol., 1997, 355, 48-56.
94. Jackisch, R.; Strittmatter, H.; Kasakov, L.; Hertting, G. Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch. Pharmacol., 1984, 327, 319-325.
95. Cunha, R. A.; Almeida, T.; Ribeiro, J. A. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats. J. Neurochem., 2001, 76, 372-382.
96. Sperlagh, B.; Zsilla, G.; Baranyi, M.; Kekes-Szabo, A.; Vizi, E. S. Age-dependent changes of presynaptic neuromodulation via A1-adenosine receptors in rat hippocampal slices. Int. J. Dev. Neurosci., 1997, 15, 739-747.
97. Rodrigues, R. J.; Canas, P. M.; Lopes, L. V.; Oliveira, C. R.; Cunha, R. A. Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. NeuroBiol. Aging, 2008, 29, 1597-1601.
98. 2A receptors in the limbic cortex, but not striatum, of aged rats. J. Neurochem., 1999, 73, 1733-1738.
99. 1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch. Pharmacol., 1991, 344, 187-192.
100. Okada, M.; Kawata, Y.; Kiryu, K.; Mizuno, K.; Wada, K.; Tasaki, H.; Kaneko, S. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J. Neurochem., 1997, 69, 2581-2588.
101. Cunha, R. A.; Ribeiro, J. A. Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology, 2000, 39, 1156-1167.
102. Kirkpatrick, K. A.; Richardson, P. J. Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes. Br. J. Pharmacol., 1993, 110, 949-954.
103. Kirk, I. P.; Richardson, P. J. Inhibition of striatal GABA release by the adenosine A2a receptor is not mediated by increases in cyclic AMP. J. Neurochem., 1995, 64, 2801-2809.
104. 1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett., 1996, 212, 53-56.
105. Zetterstrom, T.; Fillenz, M. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol., 1990, 180, 137-143.
106. Nicholls, D.; Attwell, D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci., 1990, 11, 462-468.
107. Milusheva, E.; Doda, M.; Pasztor, E.; Lajtha, A.; Sershen, H.; Vizi, E. S. Regulatory Interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem., 1992, 59, 946-952.
108. Dale, N.; Pearson, T.; Frenguelli, B. G. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol., 2000, 526, 143-155.
109. Sperlagh, B.; Zsilla, G.; Baranyi, M.; Illes, P.; Vizi, E. S. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience, 2007, 149, 99-111.
110. Sebastiao, A. M.; Ribeiro, J. A. Adenosine receptors and the central nervous system. Handb Exp Pharmacol., 2009, 193, 471-534.
111. Dixon, A. K.; Gubitz, A. K.; Sirinathsinghji, D. J.; Richardson, P. J.; Freeman, T. C. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 1996, 118, 1461-1468.
112. 1 receptors in the CA1 region of rat hippocampus: a quantitative autoradiographic study. Brain Res., 1988, 446, 161-164.
113. 1 purine receptors in rat hippocampus. Eur. J. Neurosci., 2007, 26, 890-902.
114. 2A receptors in the hippocampus and striatum of the rat. Neuroscience, 2005, 132, 893-903.
115. Johansson, B.; Halldner, L.; Dunwiddie, T. V.; Masino, S. A.; Poelchen, W.; Gimenez-Llort, L.; Escorihuela, R. M.; Fernandez-Teruel, A.; Wiesenfeld-Hallin, Z.; Xu, X. J.; Hardemark, A.; Betsholtz, C.; Herlenius, E.; Fredholm, B. B. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA, 2001, 98, 9407-9412.
116. 2A receptor in the rat striatum. J. Neurochem., 1997, 69, 315-321.
117. 1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol., 1998, 362, 17-25.
118. 2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J. Comp. Neurol., 2001, 431, 331-346.
119. Jenner, P.; Mori, A.; Hauser, R.; Morelli, M.; Fredholm, B. B.; Chen, J. F. Adenosine, adenosine A 2A antagonists, and Parkinson's disease. Parkinsonism Relat. Disord., 2009, 15, 406-413.
120. Ciruela, F.; Casado, V.; Rodrigues, R. J.; Lujan, R.; Burgueno, J.; Canals, M.; Borycz, J.; Rebola, N.; Goldberg, S. R.; Mallol, J.; Cortes, A.; Canela, E. I.; Lopez-Gimenez, J. F.; Milligan, G.; Lluis, C.; Cunha, R. A.; Ferre, S.; Franco, R. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci., 2006, 26, 2080-2087.
121. Ferre, S.; Ciruela, F.; Borycz, J.; Solinas, M.; Quarta, D.; Antoniou, K.; Quiroz, C.; Justinova, Z.; Lluis, C.; Franco, R.; Goldberg, S. R. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front. Biosci., 2008, 13, 2391-2399.
122. Ribeiro, J. A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. NeuroBiol., 2003, 68, 377-392.
123. Cunha, R. A. Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal., 2005, 1, 111-134.
124. Gerfen, C. R. Basal ganglia. In: The Rat Nervous System, Paxinos, G. Ed. Elsevier Academic: Amsterdam, 2004; pp 445-508.
125. Graybiel, A. M. The basal ganglia. Curr. Biol., 2000, 10, R509-R511.
126. Singh, N.; Pillay, V.; Choonara, Y. E. Advances in the treatment of Parkinson's disease. Prog. Neurobiol., 2007, 81, 29-44.
127. 2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur. J. Pharmacol., 2002, 451, 161-164.
128. Norenberg, W.; Wirkner, K.; Illes, P. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br. J. Pharmacol., 1997, 122, 71-80.
129. Hauber, W.; Neuscheler, P.; Nagel, J.; Muller, C. E. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur. J. Neurosci., 2001, 14, 1287-1293.
130. 2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology, (Berl) 1999, 147, 90-95.
131. 2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behav. Brain Res., 2004, 148, 47-54.
132. Kurokawa, M.; Koga, K.; Kase, H.; Nakamura, J.; Kuwana, Y. Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo. J. Neurochem., 1996, 66, 1882-1888.
133. 2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. FASEB J., 2009, 24, 587-598.
134. 2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Exp. Neurol., 2003, 184, 285-294.
135. 2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications. Prog. Neurobiol., 2007, 83, 293-309.
136. Ross, G. W.; Abbott, R. D.; Petrovitch, H.; Morens, D. M.; Grandinetti, A.; Tung, K. H.; Tanner, C. M.; Masaki, K. H.; Blanchette, P. L.; Curb, J. D.; Popper, J. S.; White, L. R. Association of coffee and caffeine Intake with the risk of Parkinson disease. JAMA, 2000, 283, 2674-2679.
137. Chen, J. F.; Moratalla, R.; Impagnatiello, F.; Grandy, D. K.; Cuellar, B.; Rubinstein, M.; Beilstein, M. A.; Hackett, E.; Fink, J. S.; Low, M. J.; Ongini, E.; Schwarzschild, M. A. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc. Natl. Acad. Sci. USA, 2001, 98, 1970-1975.
138. 2A receptor blockade in experimental models of Parkinson's disease. J. Neurochem., 2002, 80, 262-270.
139. Xu, K.; Xu, Y. H.; Chen, J. F.; Schwarzschild, M. A. Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci. Lett., 2002, 322, 13-16.
140. 2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann. Neurol., 2008, 63, 338-346.
141. 2A receptors. Naunyn Schmiedebergs Arch. Pharmacol., 1996, 353, 261-271.
142. 2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient "weaver" mouse. Neurochem. Int., 2009, 56, 245-249.
143. 2A receptors and Parkinson's disease. Handb. Exp. Pharmacol., 2009, 193, 589-615.
144. Ferguson, A. L.; Stone, T. W. Glutamate-induced depression of EPSP-spike coupling in rat hippocampal CA1 neurons and modulation by adenosine receptors. Eur. J. Neurosci., 2010, 31, 1208-1218.
145. 2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochem. Int., 2009, 56, 51-58.
146. 1 receptors impairs the recovery of synaptic transmission after hypoxia. Neuroscience, 2005, 132, 575-580.
147. Vizi, E. S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int., 1998, 33, 359-366.
148. Vizi, E. S.; Sperlagh, B. Separation of carrier mediated and vesicular release of GABA from rat brain slices. Neurochem. Int., 1999, 34, 407-413.
149. 1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro. Eur. J. Neurosci., 2004, 20, 1197-1204.
150. Lauro, C.; Di Angelantonio, S.; Cipriani, R.; Sobrero, F.; Antonilli, L.; Brusadin, V.; Ragozzino, D.; Limatola, C. Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol., 2008, 180, 7590-7596.
151. 1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology, 2010, 35, 1550-1559.
152. Szelenyi, J. Cytokines and the central nervous system. Brain Res. Bull., 2001, 54, 329-338.
153. Geiger, J. D. Buscemi, L. Fotheringham J.A. In: Role of Adenosine in the Control of Inflammatory Events Associated with Acute and Chronic Neurodegenerative Disorders. Adenosine receptors therapeutic aspects for inflammatory and immune disorders. Eds., György Haskó, Bruce N. Crostein, Csaba Szabó, Taylor & Francis Group: 2007; pp 213-236.
154. Hasko, G.; Nemeth, Z. H.; Vizi, E. S.; Salzman, A. L.; Szabo, C. An agonist of adenosine A3 receptors decreases Interleukin-12 and Interferon-gamma production and prevents lethality in endotoxemic mice. Eur. J. Pharmacol., 1998, 358, 261-268.
155. Wei, J.; Li, H.; Qu, W.; Gao, Q. Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design. Neurochem. Int., 2009, 55, 637-642.
156. 2A receptors in ischemia. Ann. N. Y. Acad. Sci., 2001, 939, 74-84.
157. 2A receptor regulation of neuroinflammation and traumatic brain injury. J. Neurosci., 2010, 30, 5802-5810.
158. Broad, R. M. A1, but not A2A, Adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex. J. Pharm. Exp. Therap., 1995, 277, 193-197.
159. Stone, T. W.; Ceruti, S.; Abbracchio, M. P. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb. Exp. Pharmacol., 2009, 193, 535-587.
160. Cognato, G. P.; Agostinho, P. M.; Hockemeyer, J.; Muller, C. E.; Souza, D. O.; Cunha, R. A. Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J. Neurochem., 2009, 112, 453-462.
161. During, M. J.; Spencer, D. D. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol., 1992, 32, 618-624.
162. Ohta, Y.; Nariai, T.; Kurumaji, A.; Hirakawa, K.; Ohno, K. Increased binding of inhibitory neuronal receptors in the hippocampus in kainate-treated rats with spontaneous limbic seizures. J. Clin. Neurosci., 2010, 17, 612-616.
163. Roseti, C.; Martinello, K.; Fucile, S.; Piccari, V.; Mascia, A.; Di Gennaro, G.; Quarato, P. P.; Manfredi, M.; Esposito, V.; Cantore, G.; Arcella, A.; Simonato, M.; Fredholm, B. B.; Limatola, C.; Miledi, R.; Eusebi, F. Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors. Proc. Natl. Acad. Sci. USA, 2008, 105, 15118-15123.
164. Ferre, S.; Fredholm, B. B.; Morelli, M.; Popoli, P.; Fuxe, K. Adenosine-dopamine receptor-receptor Interactions as an Integrative mechanism in the basal ganglia. Trends Neurosci., 1997, 20, 482-487.
165. 2A receptors in psychiatric disorders. Curr. Pharm. Des., 2008, 14, 1512-1524.
166. 1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur. J. Pharmacol., 1984, 97, 341-342.
167. 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacology, 2003, 45, 201-210.
168. Fastbom, J.; Fredholm, B. B. Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol. Scand, 1985, 125, 121-123.
169. 1 receptor. Eur. J. Pharmacol., 1997, 340, 301-310.
170. Feuerstein, T. J.; Hertting, G.; Jackisch, R. Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur. J. Pharmacol., 1985, 107, 233-242.
171. Michaelis, M. L.; Michaelis, E. K.; Myers, S. L. Adenosine modulation of synaptosomal dopamine release. Life Sci., 1979, 24, 2083-2092.
172. Honda, S.; Sasaki, Y.; Ohsawa, K.; Imai, Y.; Nakamura, Y.; Inoue, K.; Kohsaka, S. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci., 2001, 21, 1975-1982.
173. Bennett, G. C.; Boarder, M. R. The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices. Br. J. Pharmacol., 2000, 131, 617-623.
174. 7 receptors in the nervous system. Prog. NeuroBiol., 2006, 78, 327-346.
175. 1 receptors mediate retinotectal presynaptic inhibition: uncoupling by C-kinase and role in LTP during regeneration. J. NeuroPhysiol., 1998, 79, 501-510.
176. Zhang, W.; Linden, D. J. Neuromodulation at single presynaptic boutons of cerebellar parallel fibers is determined by bouton size and basal action potential-evoked Ca transient amplitude. J. Neurosci., 2009, 29, 15586-15594.